Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy
US12187742B2 · kind B2 · utility
0Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2020 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Aug 13, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the Formula (I), (II), and (III): as well as pharmaceutically acceptable salts thereof, wherein the substituents are those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of oncologic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.